SCHEMBL349749

SCHEMBL349749

O=C1C=CC(=O)N1CCOCCOCCN1C(=O)C=CC1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 9/20 1.00
FAAH O00519 5/20 0.56
ALDH1A1 P00352 2/20 0.54
LMNA P02545 2/20 0.54
MAPT P10636 2/20 0.54
NPSR1 Q6W5P4 2/20 0.54
HSP90AA1 P07900 1/20 0.54
TLR9 Q9NR96 1/20 0.54
TP53 P04637 1/20 0.54
PKM P14618 1/20 0.54
HPGD P15428 1/20 0.54
XBP1 P17861 1/20 0.54
MAPK1 P28482 1/20 0.54
HTT P42858 1/20 0.54
RECQL P46063 1/20 0.54
RAB9A P51151 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
GPR35 Q9HC97 1/20 0.54
GPR55 Q9Y2T6 1/20 0.54
PTGS1 P23219 7/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30009171 1.00 MGLL (1.00) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL15483488 1.00 MGLL (1.00) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL9643398 1.00 MGLL (1.00) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL15082420 1.00 MGLL (1.00) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL140275 1.00 MGLL (1.00) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL407969 0.97 MGLL (0.95) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL16625603 0.91 MGLL (0.83) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL19708788 0.91 MGLL (0.83) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL24797580 0.89 MGLL (0.80) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL21014255 0.89 MGLL (0.80) MGLLFAAHALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4623081-A2 SPLIT SYNTHESIS OF LONG RNAS Prime Medicine, Inc. (US) 2025-10-01 EP claimed
EP-4541374-A2 DEFINED MULTI-CONJUGATE OLIGONUCLEOTIDES Mpeg LA, L.l.c. (US) 2025-04-23 EP claimed
CN-119431734-A Polymer composite material with self-repairing conductive function and preparation method and application thereof 东华大学 2025-02-14 CN claimed
CN-118994872-A Multifunctional thermal reversible 3D printing material and preparation method thereof 中山大学 2024-11-22 CN claimed
US-20240327681-A1 BONDING SYSTEM DDP SPECIALTY ELECTRONIC MATERIALS US LLC (US) 2024-10-03 US claimed
US-20240191240-A1 DEFINED MULTI-CONJUGATES OLIGONUCLEOTIDES MPEG LA L L C (US) 2024-06-13 US claimed
WO-2024112876-A2 SPLIT SYNTHESIS OF LONG RNAS PRIME MEDICINE, INC. (US) 2024-05-30 WO claimed
US-20240150766-A1 MULTI-CONJUGATE OF SIRNA AND PREPARING METHOD THEREOF KIP CO LTD (KR) 2024-05-09 US claimed
CN-117903035-A Maleimide resin, process for producing the same, 3D-printable maleimide resin composition, process for producing the same, and device produced therefrom 上海信斯帝克新材料有限公司 2024-04-19 CN claimed
CN-113717455-B Resin composition, thermoplastic resin composite material, and thermoplastic resin article 中国石油化工股份有限公司 2023-12-29 CN claimed
US-20160175218-A1 SHAPING KERATIN FIBERS USING ARABINOSE AND ETHYLENE CARBONATE THE PROCTER & GAMBLE COMPANY 2016-06-23 US claimed
US-20160175219-A1 SHAPING KERATIN FIBERS USING ARABINOSE AND ETHYLENE CARBONATE THE PROCTER & GAMBLE COMPANY 2016-06-23 US claimed
US-20140024278-A1 Synthesized Resins and Varnishes and Prepegs and Laminates Made Therefrom ISOLA USA CORP. (US) 2014-01-23 US claimed
EP-1287064-B1 MOLECULAR WEIGHT MODIFICATION OF THERMOPLASTIC POLYMERS CIBA SC HOLDING AG (CH) 2006-03-22 EP claimed
US-6949594-B2 Molecular weight modification of thermoplastic polymers CIBA SPECIALTY CHEMICALS CORP. (US) 2005-09-27 US claimed
US-20050197433-A1 Molecular weight modification of thermoplastic polymers CIBA SPECIALTY CHEMICALS CORP. 2005-09-08 US claimed
US-20030176588-A1 Molecular weight modification of thermoplastic polymers CIBA SPECIALTY CHEMICALS CORP. 2003-09-18 US claimed
EP-0890615-B1 High temperature crosslinkable liquid crystalline polyester compositions DAINIPPON INK & CHEMICALS (JP) 2000-05-03 EP claimed
EP-0890615-A1 High temperature crosslinkable liquid crystalline polyester compositions DAINIPPON INK AND CHEMICALS, INC. (JP) 1999-01-13 EP claimed
US-4238591-A BIS-MALEIMIDE, SILANEDIOL OR SILOXANE RHONE-POULENC INDUSTRIES (FR) 1980-12-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240191240-A1 DEFINED MULTI-CONJUGATES OLIGONUCLEOTIDES TLR9, TELO2, NSUN3 MGLL 3903/4885FAAH 4804/4885ALDH1A1 2205/4885
US-20160175219-A1 SHAPING KERATIN FIBERS USING ARABINOSE AND ETHYLENE CARBONATE KRT18, COL14A1, COL2A1 MGLL 2142/4885FAAH 2227/4885ALDH1A1 2825/4885
US-20160175218-A1 SHAPING KERATIN FIBERS USING ARABINOSE AND ETHYLENE CARBONATE KRT18, COL14A1, HKDC1 MGLL 4478/4885FAAH 2841/4885ALDH1A1 1468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.